Abivax stock plunges on cancer signal in ulcerative colitis trial

Abivax stock plunges on cancer signal in ulcerative colitis trial

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.